Introduction {#S1}
============

Aspergillosis is a major health problem, with rapidly evolving epidemiology and new groups of at-risk patients ([@B73]). Aspergillosis infections are usually caused by inhalation of airborne asexual spores (conidia) of *Aspergillus fumigatus* and a few other *Aspergillus* species ([@B80]). Aspergillosis covers a spectrum of diseases ([@B59]). For example, non-invasive diseases caused by *Aspergillus*, such as aspergilloma, are currently classified as chronic pulmonary aspergillosis and are commonly associated to pulmonary tuberculosis ([@B23]). In atopic patients, the most severe form of aspergillosis is allergic bronchopulmonary aspergillosis (ABPA), which develops following sensibilization to *A. fumigatus* allergens in atopic patients with cystic fibrosis or individuals with genetic predisposition to ABPA ([@B3]). However, the most common invasive type of infection is invasive pulmonary aspergillosis (IPA), whose risk is significantly increased in immunocompromised individuals, in patients with acute leukemia and recipients of hematopoietic stem cells transplantation, or in solid-organ transplant recipients ([@B16]). Importantly, IPA has recently been described in new groups of traditionally low-risk patients, such as patients in intensive care units recovering from bacterial sepsis ([@B59]).

Although *A. fumigatus* is the major etiologic agent of aspergillosis, a few other *Aspergillus* species, such as *Aspergillus flavus*, *Aspergillus terreus*, *Aspergillus niger*, and *Aspergillus nidulans*, can also cause infections ([@B103]). While most of these pathogens can be phenotypically easily distinguished, infections can also be caused by *Aspergillus* species that are morphologically very similar to *A. fumigatus* ([@B80]). These close pathogenic relatives of *A. fumigatus* are considered sibling species or cryptic species because they are undistinguishable from each other and from *A. fumigatus* by classical identification methods ([@B4]); these species vary mostly in their colony growth, robustness of the production of conidia, conidial surface markings, presence and absence of septation in phialides, and maximum growth temperatures ([@B92]; [@B7]; [@B50]). As a result of their near identical morphological characteristics, most of these cryptic species have only recently been described. For example, *Aspergillus lentulus* was first described in 2005 in a case of human aspergillosis ([@B7]). Similarly, *A. fumigatiaffinis*, another pathogenic species that is closely related to *A. fumigatus*, was first described in 2005 ([@B44]). Even though cryptic species were only discovered relatively recently, understanding their genetic and phenotypic similarities and differences from the major pathogen *A. fumigatus* is important for two reasons. First, their prevalence in the clinic has been estimated to be between 11 and 19% ([@B8]; [@B4]; [@B69]). Second, several of these species, including *A. lentulus* and *A. fumigatiaffinis*, have been shown to differ in their drug susceptibility to amphotericin B and azoles compared to *A. fumigatus* ([@B4]).

Antifungal resistance is of worldwide concern in human pathogenic *Aspergillus* species as well as in many other human, animal, and plant fungal pathogens ([@B72]; [@B81]). Several antifungal-resistance mechanisms have been proposed in fungi ([@B81]; [@B74]). In azole-resistant *Aspergillus* strains, known mechanisms are particularly well-described in genes of the cytochrome P450 sterol 14 α-demethylase family (*cyp51*), and include sequence variants in diverse positions of the Cyp51A protein sequence (e.g., G54, G138, M220, G448, Y121, P216, F219, A284, Y431, G432, and G434; reviewed in [@B99]; [@B74]), as well as combinations of the aforementioned protein sequence changes with tandem repeat (TR) variants in the promoter region, such as TR34/L98H or TR46/Y121F/T289A (reviewed in [@B99]). Non-*cyp51* based mechanisms of antifungal resistance, such as in multidrug efflux pumps and pathways such as ergosterol biosynthesis and stress response, have also been proposed ([@B74]). Mechanisms of echinocandin resistance have mostly been attributed to FKS subunits of glucan synthase ([@B81]). While most of these studies are in *Candida* species ([@B25]; [@B32]), a recent study in *A. fumigatus* also observed mutations associated with echinocandin resistance ([@B47]).

An emerging realization in the study of *Aspergillus* pathogens is the presence of phenotypic heterogeneity among strains of the same species ([@B51]). For example, recent studies have shown how variation in hypoxic growth phenotypes is associated with virulence among *A. fumigatus* strains ([@B54], [@B55]). Similarly, *A. fumigatus* strains have previously been shown to exhibit great quantitative and qualitative heterogeneity in light response ([@B31]); in this case, heterogeneity in light response was not associated with heterogeneity in virulence. Finally, [@B77] found a high heterogeneity among *A. fumigatus* strains with regard to nitrogen acquisition and metabolism during infection and correlation between nitrogen catabolite repression-related protease secretion and virulence. These studies highlight the biological and clinical relevance of understanding strain heterogeneity in *Aspergillus* pathogens, especially with respect to virulence and antifungal drug susceptibility. However, comparisons of strain heterogeneity in virulence and drug resistance profiles among clinical strains in *A. fumigatus* and closely related cryptic species, such as *A. lentulus* and *A. fumigatiaffinis*, are lacking.

To address this gap in the field, we phenotypically characterized and sequenced the genomes of 15 clinical strains of *A. fumigatus*, *A. lentulus*, and *A. fumigatiaffinis* from Spain. At the phenotypic level, we found strain heterogeneity in both virulence and drug susceptibility profiles within each species as well as differences in drug susceptibility profiles between the three species. Interestingly, we found that the virulence profiles of the three species were similar. At the genomic level, we found that gene families known to influence drug susceptibility, such as *cyp51*, exhibit variation in their numbers of paralogs and sequence among these species and strains. Similarly, we found variability in the number of paralogs within and between species in many genes known to be important for virulence in *A. fumigatus*. Characterization of the genomic similarities and differences of clinical strains of *A. lentulus*, *A. fumigatiaffinis*, *and A. fumigatus* that vary in disease-relevant traits will advance our understanding of the variation in pathogenicity between *Aspergillus* species and strains that are collectively responsible for the vast majority of aspergillosis infections in humans.

Materials and Methods {#S2}
=====================

Strains and Species Identification {#S2.SS1}
----------------------------------

To understand the degree of genomic heterogeneity among strains, we sequenced six clinical strains of *A. fumigatus*, five of *A. lentulus*, and four of *A. fumigatiaffinis* available in the Mycology Reference Laboratory of the National Center for Microbiology (CNM) in Instituto de Salud Carlos III in Spain ([Supplementary Table S1](#SM1){ref-type="supplementary-material"}). For initial species identification, we sequenced the Internal Transcribed Spacer region (ITS) and beta-tubulin (*benA*) gene amplicons (primer pairs in [Supplementary Table S2](#SM1){ref-type="supplementary-material"}). We downloaded reference sequences for the type strains of *A. fumigatiaffinis* IBT12703 and *A. lentulus* IFM54703, and of *Aspergillus clavatus* NRRL1 (section *Clavati*), which we used as the outgroup. We aligned DNA sequences with MAFFT v.7.397 ([@B49]), followed by model selection and phylogenetic inference in IQ-TREE v.1.6.7 ([@B70]).

Characterization of Virulence and Antifungal Susceptibility Profiles {#S2.SS2}
--------------------------------------------------------------------

To understand the pathogenic potential of the 15 clinical strains, we carried out virulence assays using the moth *Galleria mellonella* model of fungal disease ([@B30]; [@B84]). Briefly, we obtained moth larvae by breeding adult moths that were kept for 24 h prior to infection under starvation, in the dark, and at a temperature of 37°C. We selected only larvae that were in the sixth and final stage of larval development. We harvested fresh asexual spores (conidia) from each strain from yeast extract-agar-glucose (YAG) plates in PBS solution and filtered through a Miracloth (Calbiochem). For each strain, we counted the spores using a hemocytometer and created a 2 × 10^8^ conidia/ml stock suspension. We determined the viability of the administered inoculum by plating a serial dilution of the conidia on YAG medium at 37°C. We inoculated 5 μl (1 × 10^6^ conidia/larvae) to each larva (*n* = 10). We used as the control a group composed of larvae inoculated with 5 μl of PBS. We performed inoculations via the last left proleg using a Hamilton syringe (7000.5KH). After infection, we maintained the larvae in petri dishes at 37°C in the dark and scored them daily (i.e., recorded the number of dead larvae each day) during a 10-day period. We considered larvae that did not move in response to touch as dead.

We tested the virulence of each clinical strain by infecting 10 larvae, i.e., for each strain tested we have one experimental replicate with an sample size *n* of 10. We performed two sets of analyses. First, we statistically assessed if the survival curves of different strains in a given species are identical (null hypothesis of strain homogeneity) or different (alternative hypothesis of strain heterogeneity). Second, we used strains within each species as "biological replicates" and statistically assessed if the survival curves between species were similar or different. We performed these statistical assessments using the log-rank test implemented in the survival R package ([@B93]), followed by multiple test correction of *p*-values (Benjamini and Hochberg). Scripts used to perform these analyses are available on the GitLab repository^[1](#footnote1){ref-type="fn"}^ under 'experimentalData/'.

To measure the antifungal susceptibility of the clinical strains, we applied the EUCAST (European Committee for Antimicrobial Susceptibility Testing) reference microdilution method version 9.3.1 ([@B6]), in which fungi are grown on plates with increasing concentrations of antifungals and the first concentration in which fungal growth is inhibited (MIC) is recorded. For all strains, we tested their susceptibility to four antifungal drug classes: (a) Polyenes: amphotericin B (Sigma-Aldrich Quimica, Madrid, Spain); (b) Azoles: itraconazole (Janssen Pharmaceutica, Madrid, Spain), voriconazole (Pfizer SA, Madrid, Spain), and posaconazole (Schering-Plough Research Institute, Kenilworth, NJ, United States); (c) Echinocandins: caspofungin (Merck & Co. Inc., Rahway, NJ, United States), micafungin (Astellas Pharma Inc., Tokyo, Japan), and anidulafungin (Pfizer SA, Madrid, Spain); and (d) Allylamines: Terbinafine (Novartis, Basel, Switzerland). The final concentrations tested ranged from 0.03 to 16 mg/L for amphotericin B, terbinafine, and caspofungin; from 0.015 to 8 mg/L for itraconazole, voriconazole and posaconazole; from 0.007 to 4 mg/L for anidulafungin; and from 0.004 to 2 mg/L for micafungin. *A. flavus* ATCC 204304 and *A. fumigatus* ATCC 204305 were used as quality control strains in all tests performed. MICs for amphotericin B, itraconazole, voriconazole, posaconazole, and terbinafine, and minimal effective concentrations (MECs) for anidulafungin, caspofungin, and micafungin were visually read after 24 and 48 h of incubation at 35°C in a humid atmosphere. To assess the relationship between antifungal susceptibility and strain/species identification, we carried out principal component analysis (PCA) with scaled MIC/MEC values with the R package FactoMineR ([@B60]), and data visualization with the factoextra v.1.0.6 package. Scripts used to perform these analyses are available on the GitLab repository (see text footnote 1) under 'experimentalData/'.

Genome Sequencing {#S2.SS3}
-----------------

To understand the genomic similarities and differences within and between these pathogenic *Aspergillus* species and how they are associated with differences in drug susceptibility and virulence profiles, we sequenced the genomes of all 15 strains. Each strain was grown in glucose-yeast extract-peptone (GYEP) liquid medium (0.3% yeast extract and 1% peptone; Difco, Soria Melguizo) with 2% glucose (Sigma-Aldrich, Spain) for 24 h to 48 h at 30°C. After mechanical disruption of the mycelium by vortex mixing with glass beads, genomic DNA of isolates was extracted using the phenol--chloroform method ([@B43]). The preparation of DNA libraries was performed using the Nextera^®^ TM DNA Library PrepKit (Illumina Inc., San Diego, CA, United States) according to manufacturer's guidelines. DNA quantification was carried out using the QuantiFluor^®^ dsDNA System and the QuantiFluor^®^ ST Fluorometer (Promega, Madison, WI, United States) and its quality was checked with the Agilent 2100 Bioanalyzer (Agilent Technologies Inc., Santa Clara, CA, United States). Sequencing was performed in the Illumina platform NextSeq500, following the manufacturer's protocols (Illumina Inc., San Diego, CA, United States). We performed an initial quality analysis of the sequence reads using FastQC, v.0.11.7^[2](#footnote2){ref-type="fn"}^. We inspected sequence reads for contaminants using BLAST ([@B5]) and MEGAN5 ([@B46]). We trimmed low quality bases (LEADING = 3; TRAILING = 3; SLIDINGWINDOW: windowSize = 4 and requiredQuality = 15), removing both short sequences (\<90 bp) and Nextera adaptors, with Trimmomatic v.0.38 ([@B15]).

Genome Assembly and Annotation {#S2.SS4}
------------------------------

We assembled the genomes of all strains with SPAdes v3.12.0 ([@B10]). We corrected bases, fixed mis-assemblies, and filled gaps with Pilon, v.1.22 ([@B96]). We assessed genome assembly quality using QUAST, v.4.6.3 ([@B37]). We assessed genome assembly completeness using Benchmarking Universal Single-Copy Orthologs (BUSCO) ([@B83]) and the 4,046 Eurotiomycetes BUSCO gene set (genes from OrthoDB that are thought to be universally single copy). We carried out gene prediction with AUGUSTUS v.3.3.1 ([@B86]) using the gene models of *A. fumigatus* Af293 strain ([@B71]) as reference. We carried out functional annotation with InterProScan 5.34-73.0 ([@B48]).

Orthogroup Identification {#S2.SS5}
-------------------------

To identify orthologs (and closely related paralogs) across strains, we performed all-vs.-all searches with blastp 2.7.1+ ([@B5]) using the strains' predicted proteomes. We used OrthoFinder v.2.3.3 ([@B27]) to generate orthogroups using pre-computed BLAST results (-og option) and a Markov Clustering (MCL) inflation value of 1.5. We considered an orthogroup "species-specific" if it possessed one or more protein sequences from only one species. Information on performing these analyses is available on the GitLab wiki page 'orthology-calling^[3](#footnote3){ref-type="fn"}^'.

Identification of Single Nucleotide Polymorphisms and Insertions/Deletions {#S2.SS6}
--------------------------------------------------------------------------

To characterize genetic variation within and between the three pathogenic *Aspergillus* species, we assessed single nucleotide polymorphisms (SNPs) and insertions/deletions (indels). We used BWA-MEM v.0.7.17 ([@B61]) with default parameters to map reads to the reference genome sequences for *A. fumigatus*, *A. lentulus*, and *A. fumigatiaffinis* (CNM-CM8686, CNM-CM7927, and CNM-CM6805, respectively). We did not use type strains as reference genomes for the species under study, because they are not from Spain. Duplicate reads were identified using PICARD MarkDuplicates, v.2.9.2^[4](#footnote4){ref-type="fn"}^. We indexed genomes using SAMTOOLS v.1.8 ([@B62]) for subsequent variant detection analyses.

We used GenomeAnalysisTK (GATK) v.3.6 for SNP calling with the recommended hard filtering parameters ([@B65]; [@B24]). We used SnpEff v.4.3t ([@B19]) to annotate and predict the functional effect of SNPs and indels. Variants assumed to have high (disruptive) impact in the protein, probably causing protein truncation, loss of function or triggering nonsense mediated decay were classified as "high," variants assumed that might change protein effectiveness but were non-disruptive were classified as "moderate," and variants most likely to be harmless or unlikely to change protein behavior were classified as "low." Finally, non-coding variants or variants affecting non-coding genes, where predictions are difficult or there is no evidence of impact, were classified as "modifier." Details can be found on the SnpEff manual^[5](#footnote5){ref-type="fn"}^.

We aligned protein and coding sequences for genes of interest with MAFFT v.7.397 ([@B49]), using the --auto mode. We used Jalview v.2.10.3 ([@B97]) to visualize SNPs, and a Python script to recover non-synonymous mutations compared to the reference, *A. fumigatus* A1163. Enrichment analysis of GO terms in genes with high impact SNPs and indels for each species was carried out with GOATOOLS v.0.9.9 ([@B53]). Scripts used to perform these analyses are available on the GitLab repository (see text footnote 1) under 'genomePolymorphisms/' and 'goatools/'.

Genetic Determinants Important for Virulence {#S2.SS7}
--------------------------------------------

To examine whether SNPs, indels, and number of paralogs in a given orthogroup were associated with virulence, we recovered 215 genes in *A. fumigatus* Af293 considered genetic determinants of virulence based on their presence in PHI-base ([@B100]) and in previously published studies ([@B1]; [@B52]). We obtained functional annotation of these virulence-related genes from FungiDB ([@B11]).

Maximum-Likelihood Phylogenomics {#S2.SS8}
--------------------------------

To reconstruct the evolutionary history of our 15 strains and closely related *Aspergillus* species, we first downloaded or assembled genomes of other strains of the three pathogenic species or their closely relatives that are publicly available. Specifically, we downloaded the genomes of *Aspergillus novofumigatus* IBT16806 ([@B52]), *Aspergillus lentulus* IFM 54703^T^ ([@B56]), *Aspergillus fischeri* NRRL181 ([@B28]), *Aspergillus udagawae* IFM46973 ([@B57]), and *Aspergillus viridinutans* FRR_0576 (GenBank accession: [GCA_004368095.1](GCA_004368095.1)). To ensure our analyses also captured the genetic diversity of *A. fumigatus*, we also included additional *A. fumigatus* genomes that spanned the known diversity of *A. fumigatus* strains ([@B63]). Specifically, we downloaded the genomes of *A. fumigatus* A1163 ([@B28]) and *A. fumigatus* Af293 ([@B71]). Additionally, we obtained the raw reads of *A. fumigatus* strains 12-750544 and F16311 (SRA accessions: SRR617737 and ERR769500, respectively). To assemble these genomes, we first quality-trimmed the sequence reads using Trimmomatic, v0.36 ([@B15]) using parameters described elsewhere (leading:10, trailing:10, slidingwindow:4:20, and minlen:50). The resulting quality-trimmed reads were then used for genome assembly using SPAdes, v3.8.1 ([@B10]), using the 'careful' parameter and the 'cov-cutoff' parameter set to 'auto.' Altogether, we analyzed a total of 24 genomes.

To identify single-copy orthologous genes among the 24 genomes, we implemented the BUSCO, v.2.0.1 pipeline ([@B98]; [@B83]). Specifically, we used the BUSCO pipeline to identify single-copy orthologous genes from genomes using the Eurotiomycetes database of 4,046 orthologs from OrthoDB, v9 ([@B98]). Among the 4,096 orthologs, we identified 3,954 orthologs with at least 18 taxa represented and aligned the protein sequence each ortholog individually using Mafft, v7.294b ([@B49]), with the same parameters as described elsewhere ([@B87]). We then forced nucleotide sequences onto the protein alignment with a custom Python, v3.5.2 script (indicated on the Gitlab repository README.md file) using BioPython, v1.7 ([@B20]). The resulting nucleotide alignments were trimmed using trimAl, v1.4 ([@B17]), with the 'gappyout' parameter. The trimmed alignments were then concatenated into a single matrix with 7,147,728 sites. We then used the concatenated data matrix as input into IQ-TREE, v1.6.11 ([@B70]), with the 'nbest' parameter set to 10. The best-fitting model of substitutions was automatically determined using the Bayesian information criterion. The best-fitting model was a general time general time-reversible model with empirical base frequencies, a discrete Gamma model with 4 rate categories, and a proportion of invariable sites (GTR+I+F+G4) ([@B91]; [@B101], [@B102]; [@B95]). Lastly, we evaluated bipartition support using 5,000 ultrafast bootstrap approximations ([@B42]).

In order to build the phylogeny with Cyp51 paralogs, we recovered protein sequences from two orthogroups that included Cyp51A and Cyp51B from *A. fumigatus* Af293 (Afu4g06890 and Afu7g03740, respectively). We generated a maximum-likelihood phylogeny in IQ-Tree v. 1.6.12 ([@B70]), using 1000 Ultrafast Bootstrap Approximation (UFBoot) replicates. The LG+G4 model was chosen as the best according to Bayesian Information Criterion. The protein sequences and tree files are available on the GitLab repository (see text footnote 1) under 'AntifungalGenes/'.

Results {#S3}
=======

Clinical Strains Show Varying Antifungal Drug Susceptibility {#S3.SS1}
------------------------------------------------------------

To study susceptibility to antifungals across all strains of the three *Aspergillus* pathogens, we employed the EUCAST reference microdilution method with the four different known classes of antifungal drugs ([Table 1](#T1){ref-type="table"}). By performing PCA on the antifungal drug susceptibility values of all 15 strains, we found that the strains exhibited high heterogeneity in their drug resistance profiles ([Figure 1A](#F1){ref-type="fig"}). In many cases, we found that strains from different species were more similar to each other (e.g., strain CNM-CM8686 from *A. fumigatus* with strain CNM-CM6069 from *A. lentulus*) than to other strains from the same species (e.g., strain CNM-CM8686 with strain CNM-CM8057 from *A. fumigatus*), highlighting the magnitude of heterogeneity in drug susceptibility of these species and strains. Principal component 1 (PC1) explained 37.2% of the variation and separated almost all *A. fumigatus* strains from those of the other two species. Principal component 2 (PC2) explained 21% of the variation, but did not separate species. The individual contributions of each antifungal drug to each PC are shown in [Supplementary Figure S1](#SM2){ref-type="supplementary-material"}. Finally, we found that the susceptibility of amphotericin B (in the polyenes class) was negatively correlated with micafungin (echinocandins) and terbinafine (allylamines), whereas anidulafungin (echinocandins) and voriconazole (azoles) were positively correlated ([Supplementary Figure S2](#SM3){ref-type="supplementary-material"}). Interestingly, the drugs exhibiting these negative or positive correlations are from different classes (e.g., polyenes *versus* allylamines or echinocandins *versus* azoles).

###### 

Susceptibility profile of cryptic *Aspergillus* species isolated in the Mycology Reference Laboratory of Spain.

  **Species**                           **Strain identifier**                                    **MIC (mg/L)**   **MEC (mg/L)**                                           
  ------------------------------------- -------------------------------------------------------- ---------------- ---------------- ------- ------- ------- ------- ------- -------
  *Aspergillus lentulus*                CNM-CM6069                                               8                0.5              2       0.12    0.5     1       0.015   0.015
                                        CNM-CM6936                                               16               0.5              4       0.25    2       2       0.03    0.03
                                        CNM-CM7927                                               8                0.5              2       0.12    0.5     0.06    0.015   0.007
                                        CNM-CM8060                                               0.12             0.25             1       0.12    0.5     2       0.06    0.03
                                        CNM-CM8694                                               2                0.12             0.25    0.06    32      0.03    0.03    MD
                                        CNM-CM8927                                               16               2                1       0.25    2       0.25    0.015   0.015
  *Aspergillus fumigatiaffinis*         CNM-CM5878                                               1                0.25             0.5     0.06    0.25    1       0.03    0.015
                                        CNM-CM6457                                               16               16               2       0.25    1       0.25    0.03    0.007
                                        CNM-CM6805                                               16               0.25             2       0.12    0.25    0.5     0.03    0.03
                                        CNM-CM8980                                               16               0.5              2       0.5     0.5     0.12    0.007   0.015
  *Aspergillus fumigatus*               CNM-CM8057                                               0.25             \>8              \>8     1       16      0.5     0.06    0.12
                                        CNM-CM8714                                               0.25             \>8              4       1       4       0.25    0.007   0.03
                                        CNM-CM8812                                               0.25             0.25             0.5     0.12    1       0.25    0.03    0.03
                                        CNM-CM8686                                               0.5              0.25             0.25    0.12    2       0.25    0.015   0.015
                                        CNM-CM8689                                               1                1                8       0.25    16      0.5     0.125   0.03
                                        Af293                                                    0.5              1                1       0.125   2       0.125   0.007   0.007
  One-way ANOVA (between species)       *P*-value                                                0.025\*          0.435            0.209   0.171   0.492   0.364   0.462   0.242
  Tukey multiple comparisons of means   *Aspergillus fumigatus -- Aspergillus fumigatiaffinis*   0.0245507\*      −                −       −       −       −       −       
                                        *Aspergillus lentulus - Aspergillus fumigatiaffinis*     0.5595621        −                −       −       −       −       −       
                                        *Aspergillus lentulus - Aspergillus fumigatus*           0.0982057        −                −       −       −       −       −       

AMB, amphotericin B; ICZ, itraconazole; VCZ, voriconazole; PCZ, posaconazole; CPF, caspofungin; MCF, micafungin; AND, anidulafungin; TRB, terbinafine. \*

P

-values \< 0.05 were considered significant.

![High heterogeneity in drug susceptibility profiles among Spanish strains of three closely related *Aspergillus* pathogens. **(A)** Principal component analysis (PCA) carried out for antifungal susceptibility testing. PC1 (Dim1) explains most of the variation (37.2% of the variation) and is able to separate *A. fumigatus* from other two species, whereas an overlap is observed in cryptic species (*A. lentulus* and *A. fumigatiaffinis*). **(B)** Antifungal susceptibility testing was carried out using the EUCAST reference microdilution method. The minimum inhibitory concentration (MIC) was obtained for AMB, VCZ, PCZ, and ICZ and the minimum effective concentration (MEC) was obtained for TRB, CPF, MCF, and AND. A lower scale is shown for echinocandins (bottom panel). Antifungal classes are A: polyenes; B: azoles; C: allylamines; D: echinocandins. AMB, amphotericin B; ICZ, itraconazole; VCZ, voriconazole; PCZ, posaconazole; CPF, caspofungin; MCF, micafungin; AND, anidulafungin; TRB, terbinafine.](fgene-11-00459-g001){#F1}

We also looked at the differences in susceptibility between strains for each antifungal drug ([Figure 1B](#F1){ref-type="fig"}). Our data show that clinical strains of *A. fumigatus* exhibit lower MICs to amphotericin B compared to *A. lentulus* and *A. fumigatiaffinis*, albeit different levels are observed among different strains (one-way ANOVA; α \< 0.05; Tukey multiple comparisons of means for amphotericin B) ([Table 1](#T1){ref-type="table"}). With the exception of susceptibility of *A. fumigatus* and *A. lentulus* to amphotericin B, for which a significant difference is observed between these two species, we observed high heterogeneity among strains of different species for the other drugs ([Table 1](#T1){ref-type="table"}). Among azoles, itraconazole and voriconazole displayed higher levels of variability across strains. With respect to terbinafine, the four *A. fumigatiaffinis* strains exhibited low MICs, whereas four *A. fumigatus* strains displayed higher MICs (MIC values \>1 mg/L) and the other two *A. fumigatus* strains even higher; finally, one *A. lentulus* strain (CNM-CM8694) displayed the highest MICs across all strains (albeit other strains showed in general lower MICs). Among echinocandin drugs, caspofungin showed high MECs for the three species. In particular, one strain of *A. fumigatiaffinis* and three of *A. lentulus* were notable in exhibiting very high MECs (MECs ≥ 1 mg/L). MECs for micafungin and anidulafungin were low (≤0.125 mg/L) for all strains.

Clinical Strains Within Each Species Show Varying Levels of Virulence {#S3.SS2}
---------------------------------------------------------------------

Given functional similarities of the greater wax moth *Galleria mellonella* innate immune system with that of mammals, and prior work showing that moth larvae and mice exhibit similar survival rates when infected with *A. fumigatus* ([@B84]; [@B66]), we infected *G. mellonella* larvae with all 15 strains to assess their virulence profiles ([Figure 2](#F2){ref-type="fig"}).

![High heterogeneity of virulence levels among Spanish strains of three closely related *Aspergillus* pathogens. We found significant heterogeneity in the survival curves between strains within *A. fumigatiaffinis* **(A)**, *A. lentulus* **(B)**, and *A. fumigatus* **(C)** (Benjamini and Hochberg adjusted *p*-values using the log-rank test are shown). We also tested differences between species (considering each strain as a biological replicate), and found that the virulence profiles of Spanish strains of all three species are not significantly different **(D)** (*p*-value using the log-rank test is shown).](fgene-11-00459-g002){#F2}

*S*urvival curves revealed high heterogeneity in virulence across clinical strains within each of the three species ([Figure 2](#F2){ref-type="fig"}). We observed highly virulent strains for which all ten larvae were dead at day 10, such as *A. fumigatus* Af293 (one of our reference strains), *A. fumigatiaffinis* CNM-CM5878 and *A. lentulus* CNM-CM8927. In contrast, other strains were less virulent and \>25% larvae survived to the last day of data collection, such as *A. lentulus* CNM-CM6069 and CNM-CM8060. Moreover, we found significant heterogeneity in the survival curves between strains within each species (Benjamini and Hochberg adjusted *p*-values: 0.00285 in *A. fumigatus*, 0.00054 in *A. fumigatiaffinis*, and 0.014 in *A. lentulus*; log-rank test) ([Figures 2A--C](#F2){ref-type="fig"}). We also tested differences between species (considering each strain as a biological replicate), and observed no significant difference between the kill curves of the various species (*p*-value = 0.17; log-rank test) -- that is, we found that both *A. lentulus* and *A. fumigatiaffinis* were as virulent as *A. fumigatus* ([Figure 2D](#F2){ref-type="fig"}).

Genomic Variation Within and Between Spanish Strains of *A. fumigatus*, *A. lentulus*, and *A. fumigatiaffinis* {#S3.SS3}
---------------------------------------------------------------------------------------------------------------

To begin exploring the potential genetic underpinnings of species and strain variation in drug susceptibility and virulence, we conducted comparative genomic analyses. The genomes of all 15 strains were of high quality and contained 97--98% of expected complete and single-copy BUSCOs ([Supplementary Table S3](#SM1){ref-type="supplementary-material"}). *A. lentulus* and *A. fumigatiaffinis* genomes had larger gene repertoires (9,717--9,842 and 10,329--10,677, respectively) than *A. fumigatus* (8,837--8,938), consistent with previous genome studies of *A. lentulus* and *A. fumigatus* ([@B71]; [@B28]; [@B56]). A genome-scale phylogenetic analysis using the nucleotide sequences of BUSCOs with previously sequenced strains ([Figure 3A](#F3){ref-type="fig"}) supports the close relationship between *A. lentulus* and *A. fumigatiaffinis*.

![Genomics of the three closely related *Aspergillus* pathogens. **(A)** Genome-scale phylogeny of the section *Fumigati* species used in this study and additional species with sequenced genomes. The *A. viridinutans* clade is presented as a sister clade. Spanish strains sequenced in this work are colored in red (*A. fumigatus*), blue (*A. lentulus*) and black (*A. fumigatiaffinis*). The newly sequenced *A. fumigatiaffinis* strains form a separated group that is closely related to *A. novofumigatus*. All *A. lentulus* strains in this work group together and share an ancestor with *A. lentulus* IFM54703, the only sequenced strain in this species to date. The *A. fumigatus* strains sequenced in this work form different internal groups in the clade with other strains in the species (e.g., strains CNM-CM8714 and CNM-CM8812 group together and strains CNM-CM8686 and CNM-CM8689 form another group). **(B)** *A. fumigatiaffinis* and *A. lentulus* shares the highest number of common orthogroups and *A. fumigatiaffinis* displays the highest number of species-specific orthogroups. We considered species-specific orthologs those that were present in at least one strain of a given species, with no representative from another species. **(C)** Orthogroups shared by all and "all but one" strains are the most frequent in three closely related *Aspergillus* pathogens. *A. lentulus*, *A. fumigatus*, and *A. fumigatiaffinis* have 9,008, 8,321, and 9,423 orthologous genes present in all strains, respectively. The five largest combinations of orthogroups are shown. As expected, the most frequent combination of orthogroups are those in all strains but one.](fgene-11-00459-g003){#F3}

Genome Diversity Among and Within Species Across Clinical Strains {#S3.SS4}
-----------------------------------------------------------------

Examination of orthogroups across the 15 strains and three species revealed that most genes (7,938) are shared by all three species ([Figure 3B](#F3){ref-type="fig"}). *A. fumigatiaffinis* has a larger set of species-specific genes (1,062) than *A. lentulus* (656) or *A. fumigatus* (645), consistent with its larger genome size and gene number. The numbers of shared genes between *A. lentulus* and *A. fumigatiaffinis* are also higher than intersections between each of them with *A. fumigatus*, consistent with their closer evolutionary relationship ([Figure 3A](#F3){ref-type="fig"}). Within each species, most orthogroups are found in all strains (9,008, 8,321, and 9,423 in *A. lentulus*, *A. fumigatus*, and *A. fumigatiaffinis*, respectively); approximately 5.4--6.13% of genes in each species appear to vary in their presence between strains ([Supplementary Figure S3](#SM4){ref-type="supplementary-material"}). Among these, we noted that orthogroups that are present all but one strain are usually the most frequent ([Figure 3C](#F3){ref-type="fig"}).

We identified a total of 114,378, 160,194, and 313,029 SNPs in *A. fumigatus*, *A. fumigatiaffinis*, and *A. lentulus*, respectively. We identified 406, 493, and 747 SNPs in *A. fumigatus*, *A. fumigatiaffinis*, and *A. lentulus*, respectively, as high-impact polymorphisms; these polymorphisms are those whose mutation is presumed to be highly deleterious to protein function. Similarly, out of a total of 11,698 (*A. fumigatus*), 20,135 (*A. fumigatiaffinis*) and 34,506 (*A. lentulus*) indels segregating within each species, we identified 615, 1,739, and 1,830 high-impact indels in *A. fumigatus*, *A. fumigatiaffinis*, and *A. lentulus*, respectively.

Gene ontology (GO) enrichment analysis was carried out for genes with high impact SNPs and indels (α = 0.05). *A. fumigatus* only showed GO terms identified as underrepresented in "cellular process" and several cellular compartments ("protein-containing complex," "intracellular organelle part," "organelle part," "cytoplasmic part," "cell part"). *A. lentulus* had "nucleoside metabolic" and "glycosyl compound metabolic processes" enriched, and *A. fumigatiaffinis* showed enriched terms for "modified amino acid binding," "phosphopantetheine binding," "amide binding," "transition metal ion binding," "zinc ion binding," "chitin binding," and "ADP binding." *A. lentulus* and *A. fumigatiaffinis* genes with high impact SNPs and indels also showed underrepresented GO terms ([Supplementary Table S4](#SM1){ref-type="supplementary-material"}). We also analyzed SNPs and indels separately ([Supplementary Table S4](#SM1){ref-type="supplementary-material"}).

Polymorphisms in Major Antifungal Target Genes Correlate With Antifungal Susceptibility {#S3.SS5}
---------------------------------------------------------------------------------------

Given the observed variation within and between species in antifungal drug susceptibility, we examined DNA sequence polymorphisms in genes known to be involved in antifungal susceptibility to azoles and echinocandins. In particular, we examined patterns of sequence variation in the 14α-sterol demethylase gene *cyp51A* (Afu4g06890) and in the 1,3-beta-glucan synthase catalytic subunit gene *fks1* (Afu6g12400). Using *A. fumigatus* A1163 as reference, we identified important species- and strain-specific polymorphisms in both *cyp51A* and *fks1* ([Figure 4A](#F4){ref-type="fig"} and [Table 2](#T2){ref-type="table"} shows a detailed breakdown of all SNP and indel polymorphisms per strain).

![Changes in important genes related to antifungal susceptibility in the three *Aspergillus* pathogens. **(A)** Products of genes related to antifungal resistance, *Cyp51A* (azoles) and *Fks1* (echinocandins), display species- and strain-specific polymorphisms. Only the positions with changes in at least one strain are shown (substitutions or insertions/deletions). Blue triangles highlight important amino acid changes in positions 98, 121, and 289 in Cyp51A and in hot spot 2 (HS2) of *Fks1*. Red triangles indicate insertions/deletions. **(B)** Promoter region of the *cyp51A* gene displays strain-specific mutations among Spanish strains of three closely related *Aspergillus* pathogens. Well-known tandem repeat regions in antifungal-resistant strains of *A. fumigatus* are shown between positions 70--140 in the alignment (i.e., TR34 and TR46, observed in CNM-CM8714 and CNM-CM8057, respectively, delimited by two blue arrows in upper part). Polymorphisms in cryptic species were also identified, for instance, the short deletions exclusively found in the cryptic species (either in *A. fumigatiaffinis* or *A. lentulus*) around positions 230--250. Red arrow and red font indicate the start codon. **(C)** Phylogeny of Cyp51 gene family (protein sequences) reveals three different members (Cyp51A, Cyp51B, and the putative Cyp51C) in *A. fumigatiaffinis*. Ultrafast Boostrap Approximation and SH-aLRT support values are shown.](fgene-11-00459-g004){#F4}

###### 

Single-nucleotide polymorphisms and insertions/deletions in *cyp51* family and *fks1* genes in each species individually.

  **Species**            **Polymorphism type**   **Gene**   **High impact variant**   **Low impact variant**   **Moderate impact variant**   **Modifier impact variant**
  ---------------------- ----------------------- ---------- ------------------------- ------------------------ ----------------------------- -----------------------------
  *A. fumigatus*         INDELs                  *cyp51A*   0                         0                        0                             6
  *A. fumigatus*         SNPs                    *cyp51A*   0                         0                        5                             23
  *A. lentulus*          INDELs                  *cyp51A*   0                         0                        0                             10
  *A. lentulus*          SNPs                    *cyp51A*   0                         8                        3                             92
  *A. fumigatus*         INDELs                  *cyp51B*   0                         0                        0                             1
  *A. fumigatus*         SNPs                    *cyp51B*   0                         1                        1                             7
  *A. lentulus*          INDELs                  *cyp51B*   0                         0                        0                             1
  *A. lentulus*          SNPs                    *cyp51B*   0                         0                        0                             2
  *A. fumigatiaffinis*   INDELs                  *cyp51C*   0                         0                        0                             28
  *A. fumigatiaffinis*   SNPs                    *cyp51C*   0                         10                       1                             157
  *A. fumigatiaffinis*   INDELs                  *fks1*     0                         0                        0                             45
  *A. fumigatiaffinis*   SNPs                    *fks1*     0                         23                       5                             143
  *A. fumigatus*         INDELs                  *fks1*     0                         0                        0                             3
  *A. fumigatus*         SNPs                    *fks1*     0                         4                        0                             10
  *A. lentulus*          INDELs                  *fks1*     4                         0                        0                             50
  *A. lentulus*          SNPs                    *fks1*     0                         43                       5                             218

HIGH = The variant is assumed to have high (disruptive) impact in the protein, probably causing protein truncation, loss of function or triggering nonsense mediated decay. MODERATE = A non-disruptive variant that might change protein effectiveness. LOW = A variant that is most likely to be harmless or unlikely to change protein behavior. MODIFIER = Usually non-coding variants or variants affecting non-coding genes, where predictions are difficult or there is no evidence of impact. Details can be found on the SnpEff manual (

http://snpeff.sourceforge.net/SnpEff_manual.html

).

An alignment of Cyp51A protein sequences in the three species shows possible insertions in different sites ([Figure 4A](#F4){ref-type="fig"} -- red arrow). We observed substitutions in at least one of the clinical strains in the three species in 42 positions that might be correlated with the strains' varying drug susceptibility levels. For instance, Cyp51A in *A. fumigatus* CNM-CM8714 revealed a well-documented substitution related to azole resistance at position 98 (L98H) ([Figure 4A](#F4){ref-type="fig"} -- blue arrows), which might be correlated to its lower susceptibility to itraconazole or voriconazole compared to other *A. fumigatus* strains ([Figure 1B](#F1){ref-type="fig"}).

We also looked at the promoter region of the *cyp51A* gene ([Figure 4B](#F4){ref-type="fig"}) and identified the TR insertions TR34 and TR46 (region highlighted between blue arrows), previously reported in antifungal resistant strains ([@B26]). These changes were specific to certain clinical strains of *A. fumigatus* and were previously reported in combination with specific point mutations leading to amino acid substitutions. For example, *A. fumigatus* CNM-CM8714 carries the TR34 promoter insertions combined with L98H ([Figure 4A](#F4){ref-type="fig"} -- blue arrow), whereas *A. fumigatus* CNM-CM8057 has a TR46 insertion combined with Y121F/T289A ([Figure 4A](#F4){ref-type="fig"} -- blue arrow). There are other variants (short indels) that were exclusive to either *A. lentulus* or *A. fumigatiaffinis*, or both.

Examination of the Fks1 protein sequence alignment from strains of the three species also revealed substitutions in 39 sites ([Figure 4A](#F4){ref-type="fig"}). We also observed an insertion at position 1,626 of *A. lentulus* CNM-CM8927 (red arrow). Fks1 also showed substitutions at positions comprising an important hot-spot 2 (HS2) (blue arrows): all *A. lentulus* strains have a substitution at position 1,349 (I1349V) and all *A. fumigatiaffinis* have a substitution at position 1,360 (T1360I).

Examination of orthogroups revealed that the orthogroup that includes the *cyp51A* gene (Afu4g06890) contained additional paralogs of the *cyp51* family in *A. fumigatiaffinis*. Thus, we carried out a phylogenetic analysis with the amino acid sequences with the orthogroups containing *cyp51A* and *cyp51B* genes in *A. fumigatus* Af293 ([Figure 4C](#F4){ref-type="fig"}) that comprises the three species in this work. We observed three well-defined clades. The *A. fumigatiaffinis* paralog related to *cyp51A* is likely to represent *cyp51C*, which has been previously reported in other *Aspergillus* species, such as *A. flavus* and *A. oryzae* ([@B38]; [@B74]). Sequence identity between the putative Cyp51C protein in *A. fumigatiaffinis* CNM-CM6805 and Cyp51C (XM_002383890.1) and Cyp51A (XM_002375082.1) of *A. flavus* ([@B64]) is 471/512 (92%) and 391/508 (77%), respectively.

Genetic Determinants Involved in Virulence: Single-Nucleotide Polymorphisms, Insertions/Deletions Across Strains and Within Species Conservation {#S3.SS6}
------------------------------------------------------------------------------------------------------------------------------------------------

To explore the genetic underpinnings of the observed strain heterogeneity in virulence we next examined the SNPs and indels in 215 genes that have previously been characterized as genetic determinants of virulence in *A. fumigatus* ([Supplementary Table S5](#SM1){ref-type="supplementary-material"}).

Most virulence genetic determinants (146 genes) were found in single-copy in all strains ([Supplementary Table S6](#SM1){ref-type="supplementary-material"}), whereas 57 genes varied in their number of paralogs across clinical strains ([Figure 5](#F5){ref-type="fig"}). We also identified four virulence determinants that had no orthologs in either *A. lentulus* or *A. fumigatiaffinis*, such as Afu6g07120 (*nudC*), which is an essential protein involved in nuclear movement ([@B68]), and considered an essential gene in *A. fumigatus* ([@B45]). Interestingly, we noted 17 virulence determinants that are present in *A. fumigatus* and *A. fumigatiaffinis* but absent in *A. lentulus* ([Figure 5](#F5){ref-type="fig"} -- top panel), such as Afu8g00200 (*ftmD*), one of the genes in the fumitremorgin biosynthetic gene cluster ([@B1]).

![Orthogroups for virulence determinants reveals variable number of paralogs among the three closely related *Aspergillus* pathogens. We searched for 215 known genetic determinants of virulence in *A. fumigatus* Af293 in the species of interest and found they were grouped into 203 orthogroups. 146/203 were found in single copy across all strains and are not shown here. The cladogram above the species reflects similarities between strain presence/absence patterns. *A. fumigatus* Af293 shows a different pattern compared to other strains of *A. fumigatus*, grouping with one of the *A. lentulus* strains (CNM-CM8927). This may reflect the phylogenetic divergence of *A. fumigatus* strain Af293 from other species members. Conidial pigment polyketide synthase *alb1* (Afu2g17600) is one of the genetic determinants of virulence with highest number of copies in cryptic species (*n* = 7) when compared to *A. fumigatus* strains (*n* = 4). Gene identifiers in *A. fumigatus* Af293 are highlighted in bold. Color scale indicates the number of genes found within the orthogroup.](fgene-11-00459-g005){#F5}

Several virulence determinants exhibited larger numbers of paralogs in one or more species. For example, the conidial pigment polyketide synthase *alb1* (Afu2g17600), which is involved in conidial morphology and virulence ([@B94]), is one of the determinants with highest number of paralogs in *A. lentulus* and *A. fumigatiaffinis* (*n* = 7) when compared to *A. fumigatus* strains (*n* = 4). For determinants that contained a gene in at least one strain, we tested correlations between number of paralogs and virulence (lethal time 50: day at which 50% of the larvae were dead, or "ND-end": the number of dead larvae at the end of the experiment) and we observed no significant correlation suggesting paralog number does not associate with virulence.

Discussion {#S4}
==========

*A. fumigatus* and the closely related species *A. lentulus* and *A. fumigatiaffinis* are important causal agents of aspergillosis ([@B104]; [@B58]). Importantly, the emergence of antifungal resistance is of increasing worldwide concern ([@B29]) and antifungal resistant strains of *A. lentulus* and *A. fumigatiaffinis* ([@B4]) have been identified. Heterogeneity in virulence across different strains of *A. fumigatus* has also been known for some time ([@B67]). Analyses of strain phenotypic and genetic heterogeneity allow us to identify correlations between phenotype and genotype in strains of *Aspergillus* pathogens.

We found that high heterogeneity exists in drug susceptibility and virulence across different strains of *A. fumigatus*, *A. lentulus*, and *A. fumigatiaffinis* ([Figures 1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}). For one specific antifungal drug, amphotericin B, our results confirmed previous findings that *A. fumigatus* is more susceptible to amphotericin B than strains of cryptic species ([@B9]). Studies on the intrinsic resistance to amphotericin B reported for *A. terreus* highlight the importance of stress response pathways, in particular heat shock proteins (such as Hsp90 and Hsp70), as well as enzymes detoxifying reactive oxygen species ([@B75]). Future work involving genomics on the cryptic species will be able to exploit changes in genetic determinants involved in amphotericin B susceptibility, although this drug is not commonly used in clinical settings. Interestingly, our PCA identified pairs of positively and negatively correlated antifungal drugs from different classes ([Supplementary Figure S2](#SM3){ref-type="supplementary-material"}), suggestive of potential synergistic effects (resistance to one drug leads to resistance to the other) and trade-offs (resistance to one drug leads to susceptibility to the other), which could be important for clinical applications.

Comparison of the three species showed that the virulence profiles of *A. fumigatiaffinis* and *A. lentulus* strains were not significantly different from the virulence profiles of *A. fumigatus* strains ([Figure 2](#F2){ref-type="fig"}). This finding is in contrast to a previous comparison of survival curves of the type strains of *A. lentulus* and *A. fumigatus*, which found that *A. fumigatus* is significantly more virulent than *A. lentulus* ([@B88]). The likely explanation for this is our finding that there is significant strain heterogeneity within each species ([Figure 2](#F2){ref-type="fig"}), suggesting that comparisons of individual strains between species are not going to be representative of the variation in virulence within species. While additional testing using diverse models of fungal disease will be required to test the validity of these observations, our findings reinforce the emerging view ([@B54], [@B55]; [@B77]; [@B12]) that examining within-species variation in *Aspergillus* pathogens is an important, yet poorly studied and understood, dimension of fungal virulence.

The advent of whole genome sequencing boosted our understanding of the biology of the genus *Aspergillus* ([@B22]). Several studies have previously analyzed genomic data of *A. fumigatus* strains ([@B2]; [@B90]), uncovering *cyp51A* mutations in *A. fumigatus* populations ([@B2]). Some studies have also used population genomic data for strains of *A. fumigatus* to gain insights on antifungal drug susceptibility ([@B33]) or virulence potential ([@B76]). Correlations between phenotypic traits, such as antifungal susceptibility or virulence and genetic traits have been also studied in other well-studied pathogens, such as the opportunistic yeast *Candida albicans* ([@B41]). However, to our knowledge, this is the first study that examines the phenotypic and genetic heterogeneity among strains of species closely related to *A. fumigatus*.

The three main classes of antifungal drugs comprise polyenes, azoles, and echinocandins, involved in ergosterol composition of fungal membrane, ergosterol biosynthesis, and the cell wall biopolymer (1,3)-β-[D]{.smallcaps}-glucan, respectively ([@B79]). Due to toxicity to host cells, polyenes are only used in exceptional cases, and first-line prophylaxis and treatment of aspergillosis is usually carried out with azoles ([@B34]; [@B35]). Mechanisms of azole resistance involving mutations in the *cyp51* genes have been identified in diverse fungi, including in multiple animal and plant pathogens ([@B72]). In *A. fumigatus*, research has focused on azole susceptibility testing and correlation with point mutations in the *cyp51A* gene and TR insertions in its promoter region ([@B18]; [@B103]). Major changes in protein *Cyp51A* that correlated with azole resistance include point mutations, such as in positions G54, G138, M220, and G448, or combination of point mutations with TRs in the promoter region, such as the TR34/L98H and the TR46/Y121F/T289A ([@B99]; [@B13]). In previous studies, alterations such as the insertion of TR34 and TR46 ([@B26]) were only found in the *cyp51A* promoter of *A. fumigatus* strains, but these have also been found in other pathogens, such as the wheat pathogen *Zymoseptoria tritici* ([@B21]). Our work explored the promoter region of the *cyp51A* gene in *A. lentulus* and *A. fumigatiaffinis*, two closely related pathogenic species, and identified these promoter region changes only in two strains of *A. fumigatus* and not in either of the two cryptic species. Interestingly, two of the *A. fumigatus* strains in this work presented the combined TR34/L98H and the TR46/Y121F/T289A. We also identified other changes in proteins encoded by *cyp51A* and *fks1* that can be used in the future to generate mutants and test the effect of mutations in well-studied wild-type strains of *A. fumigatus* ([@B18]).

The evolution of the gene families that contain genes involved in drug resistance might also give us clues on how drug resistance evolves in fungal populations; previous studies ([@B40]; [@B105]) report two paralogs of c*yp51* in diverse species, including *A. fumigatus*, *A. nidulans*, *Penicillium digitatum*, and *Magnaporthe oryzae*, while *Fusarium graminearum*, *A. flavus*, and *A. oryzae* have three *cyp51* genes ([@B26]). Recently, a study proposed the existence of *cyp51C* gene arising from a duplication in *cyp51B* in *A. terreus* and *A. carbonarius* ([@B74]). Interestingly, our study found a paralog of the *cyp51A* gene in *A. fumigatiaffinis* that likely corresponds to *cyp51C*. Whole-genome sequence analysis in *A. flavus* reported substitutions in the three paralogous genes (*cyp51A, cyp51B*, and *cyp51C*) in the context of antifungal resistance ([@B82]). Novel substitutions identified in *cyp51C* and modeling of protein changes suggested possible effects on drug binding. Next steps in studies of azole susceptibility in *A. fumigatiaffinis* strains could include the analysis of this putative *cyp51C* gene and its role in the organism's observed drug susceptibility profile.

Studies on echinocandins have focused on the (1,3)-β-[D]{.smallcaps}-glucan synthase enzyme, encoded by the *fks1* gene ([@B79]). Particularly, two hot-spots have been studied ([@B36]). Although most studies report mutations in *Candida* ([@B25]; [@B32]), previous work reported point mutations in *fks1* hot spot 1 associated with echinocandin resistance in *A. fumigatus* ([@B47]). Our work did not find changes among *A. fumigatus* clinical strains, and didn't find any mutation in the hot spot 1 of sequences of the cryptic species, which is in agreement with previous study that analyzed *fks1* sequences in *A. lentulus* ([@B85]). However, we did observe changes in hot spot 2 that were specific to the cryptic species; further examination of these changes with respect to echinocandin susceptibility is an interesting future avenue of research.

Although this study focused on polymorphisms in genes *cyp51A* and *fks1*, there is also increasing research on non-*cyp51* ([@B103]) and non-*fks1* ([@B89]) genetic changes. Future exploitation of genomic data on strains of *A. fumigatus* and closely related species could also exploit these additional genes. These future studies could also exploit new antifungal drugs, such as olorofim, which has also been tested on cryptic species of *Aspergillus* ([@B78]). Finally, future phenotypic and genomic analyses can help us to better understand more complex topics involving antifungal drugs, such as resistance, persistence, and tolerance (as well as the role of tolerance in resistance) ([@B14]). Given possible emergence of antifungal resistance in agriculture ([@B39]), future work could also exploit correlations in antifungals and the origin of these isolates.
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